Replies to post #41984 on Medizone Intl. (fka MZEIQ)

[Tane61]

Bacteria present on 'high-touch' surfaces post AsepticSure treatment


The above has been "demonstrated over and over again"


DATA: Beta Testing at Belleville General Hospital (Medizone's Canadian insider hospital)

Location: Sills451

Surface Location: Over bed table

CFU Before AsepticSure Treatment: 300

CFU After AsepticSure Treatment: 3


Location: Sills471-1

Surface Location: Inside door handle of room

CFU Before AsepticSure Treatment: 33

CFU After AsepticSure Treatment: 1


Location: Sills469

Surface Location: Bedside table

CFU Before AsepticSure Treatment: 6

CFU After AsepticSure Treatment: 5

----------

Given the above, the "rather tepid reviews" from Canadian hospitals is not surprising...

Bob Simpson(Contamination Control Corp):"...very very skeptical and slow. It's been presented to a number of people in hospitals, infection control departments etc and they think the technology is fantastic but trying to get a hospital to change its protocol that they have been working with for so long is very difficult. So we have some rather tepid reviews from the hospitals."

----------

NOT ONE (1) SALE TO A HOSPITAL NOR ONE (1) HOSPITAL SERVICE CONTRACT HAS BEEN REPORTED, WORLDWIDE (The manufacture of the first production unit was announced back in April 2012)